A detailed history of Fox Run Management, L.L.C. transactions in Mannkind Corp stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 74,024 shares of MNKD stock, worth $318,303. This represents 0.06% of its overall portfolio holdings.

Number of Shares
74,024
Previous 26,015 184.54%
Holding current value
$318,303
Previous $167,000 122.75%
% of portfolio
0.06%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$4.92 - $6.6 $236,204 - $316,859
48,009 Added 184.54%
74,024 $372,000
Q4 2024

Feb 11, 2025

BUY
$5.93 - $7.44 $154,268 - $193,551
26,015 New
26,015 $167,000
Q1 2023

May 12, 2023

BUY
$3.95 - $5.63 $181,277 - $258,377
45,893 New
45,893 $188,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.11B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.